Advertisement

Hospitals
GeoVax Labs to Present at 2010 Southern California Investor Conference on August 17
Aug 11, 2010 12:39PM
GeoVax Labs, Inc. , a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, announces that Chief Executive Officer Dr. Robert McNally and C...

Standard & Poor’s (GOVX), Hospitals, Biotechnology, Infectious Disease Control, Finance, Georgia, California

Hospitals
GeoVax Labs to Present at 2010 Southern California Investor Conference on August 17
Aug 11, 2010 12:39PM
GeoVax Labs, Inc. , a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, announces that Chief Executive Officer Dr. Robert McNally and C...

Standard & Poor’s (GOVX), Hospitals, Biotechnology, Infectious Disease Control, Finance, Georgia, California

Hospitals
GeoVax Labs, Inc. Announces Six Month 2010 Financial Results and Provides Operational Update
Aug 05, 2010 8:00AM
GeoVax Labs, Inc. , an Atlanta-based, biopharmaceutical firm (the "Company") developing vaccines that prevent and fight Human Immunodeficiency Virus infections...

Standard & Poor’s (GOVX), Hospitals, Biotechnology, Biometrics, Pharmaceutical, OTC/SmallCap, Georgia

Hospitals
GeoVax Labs, Inc. Announces Six Month 2010 Financial Results and Provides Operational Update
Aug 05, 2010 8:00AM
GeoVax Labs, Inc. , an Atlanta-based, biopharmaceutical firm (the "Company") developing vaccines that prevent and fight Human Immunodeficiency Virus infections...

Standard & Poor’s (GOVX), Hospitals, Biotechnology, Biometrics, Pharmaceutical, OTC/SmallCap, Georgia

Hospitals
GeoVax CEO Named to 'PharmaVoice 100' for 2010
Aug 02, 2010 11:48AM
Dr. Robert McNally, CEO of GeoVax Labs, Inc. , a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, has been named to the "PharmaVo...

Standard & Poor’s (GOVX), Hospitals, Biotechnology, Pharmaceutical, Publishing, Publishing, Infectious Disease Control, Georgia

Hospitals
GeoVax CEO Named to 'PharmaVoice 100' for 2010
Aug 02, 2010 11:48AM
Dr. Robert McNally, CEO of GeoVax Labs, Inc. , a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, has been named to the "PharmaVo...

Standard & Poor’s (GOVX), Hospitals, Biotechnology, Pharmaceutical, Publishing, Publishing, Infectious Disease Control, Georgia

Pharmaceutical
GeoVax Labs, Inc. Financing Update
Jul 28, 2010 8:00AM
GeoVax Labs, Inc. , an Atlanta-based, biopharmaceutical firm (the "Company") developing human vaccines and therapeutics for diseases caused by HIV-1 , previousl...

Standard & Poor’s (GOVX), Pharmaceutical, Hospitals, Georgia

Biotechnology
GeoVax's Chief Scientific Officer Interviewed on HealthRadio.net
Jul 22, 2010 12:22PM
Dr. Harriet L. Robinson, Chief Scientific Officer at GeoVax Labs, Inc. , a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, discussed ...

Standard & Poor’s (GOVX), Biotechnology, Hospitals, Pharmaceutical, TV and Radio, Entertainment, Georgia


About IBT PR Center
The IBTAnnouncement Service helps investors discover the latest information reported by companies in which they are invested, including changes in voting rights, net asset values, and more.

advertisement

Popular Tags

advertisement